Skip to contentA
Axogen, Inc.
A
AXGNAxogen, Inc. Q2 2023 · 10-Q
Revenue$38.16M$38.16M+10.7% vs Q2 2022 Net Income-$6.66M-$6.66MN/M vs Q2 2022 EPS Diluted-$0.16-$0.16N/M vs Q2 2022 Gross Profit$29,652,000+5.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Axogen, Inc. · CIK 805928 · Engraved from SEC EDGAR
Operating Cash Flowderived$292,000N/M Free Cash Flowderived-$4,123,000N/M Margins · derivedGross margin77.7%−4.0 pt vs Q2 2022
Operating margin-18.1%+4.9 pt vs Q2 2022
Net margin-17.5%+5.0 pt vs Q2 2022
ended Jun 30, 2023 · filed Aug 8, 2023 · 39 d after period end